161 related articles for article (PubMed ID: 1846418)
1. Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs.
Yoshida N; Mizumoto A; Iwanaga Y; Itoh Z
J Pharmacol Exp Ther; 1991 Jan; 256(1):272-8. PubMed ID: 1846418
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog.
Itoh Z; Mizumoto A; Iwanaga Y; Yoshida N; Torii K; Wakabayashi K
Gastroenterology; 1991 Apr; 100(4):901-8. PubMed ID: 1848200
[TBL] [Abstract][Full Text] [Related]
3. [Effect of 5-HT3 receptor antagonists on gastrointestinal motility].
Yoshida N; Ito T; Karasawa T; Iwanaga H; Mizumoto A; Ito A
Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):315-9. PubMed ID: 2562028
[No Abstract] [Full Text] [Related]
4. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
Gullikson GW; Loeffler RF; Viriña MA
J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
[TBL] [Abstract][Full Text] [Related]
7. Change of the involvement of 5-HT3 receptor in the gastric motor stimulating actions of KW-5139 (Leu13-motilin acetate) in the recovered and post-operative periods in dogs.
Yokoyama T; Takasaki K; Kitazawa T; Karasawa A; Kusaka H
Life Sci; 2000 Sep; 67(19):2281-92. PubMed ID: 11065176
[TBL] [Abstract][Full Text] [Related]
8. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model.
Langlois A; Pascaud X; Junien JL; Dahl SG; Rivière PJ
Eur J Pharmacol; 1996 Dec; 318(1):141-4. PubMed ID: 9007525
[TBL] [Abstract][Full Text] [Related]
9. [Study on mechanism of interdigestive migrating contractions of a canine stomach].
Ito S
Nihon Heikatsukin Gakkai Zasshi; 1990 Oct; 26(5):235-9. PubMed ID: 1966531
[No Abstract] [Full Text] [Related]
10. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
Yoshida N; Ito T; Karasawa T; Itoh Z
J Pharmacol Exp Ther; 1991 May; 257(2):781-7. PubMed ID: 2033519
[TBL] [Abstract][Full Text] [Related]
11. Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis.
Qin XY; Pilot MA; Thompson H; Scott M
Br J Pharmacol; 1993 Jan; 108(1):44-9. PubMed ID: 8094027
[TBL] [Abstract][Full Text] [Related]
12. 5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat.
Costall B; Domeney AM; Naylor RJ
Neuroreport; 1990 Sep; 1(1):77-80. PubMed ID: 1966601
[TBL] [Abstract][Full Text] [Related]
13. Constipation evoked by 5-HT3-receptor antagonism: evidence for heterogeneous efficacy among different antagonists in guinea-pigs.
Sanger GJ; Wardle KA
J Pharm Pharmacol; 1994 Aug; 46(8):666-70. PubMed ID: 7815281
[TBL] [Abstract][Full Text] [Related]
14. Effect of cisapride and renzapride on gastrointestinal motility and plasma motilin concentration in dogs.
Song CW; Lee KY; Kim CD; Chang TM; Chey WY
J Pharmacol Exp Ther; 1997 Jun; 281(3):1312-6. PubMed ID: 9190867
[TBL] [Abstract][Full Text] [Related]
15. The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension.
Moss HE; Sanger GJ
Br J Pharmacol; 1990 Jul; 100(3):497-501. PubMed ID: 2167734
[TBL] [Abstract][Full Text] [Related]
16. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
[TBL] [Abstract][Full Text] [Related]
17. Effect of synthetic motilin on gastric motor activity in conscious dogs.
Ito Z; Takeuchi S; Aizawa I; Takayanagi R
Am J Dig Dis; 1977 Sep; 22(9):813-9. PubMed ID: 900097
[TBL] [Abstract][Full Text] [Related]
18. Regionally selective cholinergic stimulation by BRL 24924 in the human isolated gut.
Burke TA; Sanger GJ
Br J Clin Pharmacol; 1988 Sep; 26(3):261-5. PubMed ID: 3179166
[TBL] [Abstract][Full Text] [Related]
19. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
King GL
J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
[TBL] [Abstract][Full Text] [Related]
20. BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors.
Newberry NR; Watkins CJ; Sprosen TS; Blackburn TP; Grahame-Smith DG; Leslie RA
Neuropharmacology; 1993 Aug; 32(8):729-35. PubMed ID: 8413836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
